The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Mild Cognitive Impairment: Ten Years Later
Open accessAbstract
In the past 10 years, there has been a virtual explosion in the literature concerning the construct of mild cognitive impairment. The interest in this topic demonstrates the increasing emphasis on the identification of the earliest features of cognitive disorders such as Alzheimer disease and other dementias. Mild cognitive impairment represents the earliest clinical features of these conditions and, hence, has become a focus of clinical, epidemiologic, neuroimaging, biomarker, neuropathological, disease mechanism, and clinical trials research. This review summarizes the progress that has been made while also recognizing the challenges that remain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Any interval between last clinical evaluation and autopsy creates a potential for misclassification, especially since progression to dementia typically seems to be preceded by a prodrome.33”
From Ecology of the Aging Human Brain (2011) · cites this paper as [33]
Experimental — accuracy not yet measuredIn the citing paper
“Mild neurocognitive disorder is a new addition to the DSM nomenclature, previously subsumed by the nonspecific category of 'cognitive disorder not otherwise specified, ' and represents a new framework for the commonly used diagnosis of MCI. 12”
From Classifying neurocognitive disorders: the DSM-5 approach (2014) · cites this paper as [12]
In the citing paper
“The Mayo Criteria correspond best to what is referred to as amnestic MCI in the IWG Criteria, with the main objective of the diagnosis being the identification of AD at the predementia stage.12”
From Classifying neurocognitive disorders: the DSM-5 approach (2014) · cites this paper as [12]
In the citing paper
“These memory changes related to higher or increased social isolation are similar to the rates (12%–30% decline in 2 years) found among older people with progressive memory decline (Cloutier, Chertkow, Kergoat, Gauthier, & Belleville, 2015) and mild cognitive impairment (Petersen et al., 2009) prior to dementia, compared with 2%–4% biannual decline in normal aging.”
From Social isolation and memory decline in later-life (2020) · cites this paper as Petersen et al., 2009
In the citing paper
“Thus, AMCI is considered a high risk group for dementia [6] and has become a common target for secondary prevention.”
From Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial (2016) · cites this paper as [6]
In the citing paper
“The natural history of AD starts slowly in late middle age with mild memory deficits that progress to amnestic mild cognitive impairment (AMCI) [6], which in turn progresses to dementia [7].”
From Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial (2016) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Self-citationMild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Self-citationWinblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Self-citationCurrent concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Self-citationImaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Gauthier, S. G., Reisberg, ., Zaudig, M., Petersen, R. C., Ritchie, K. A., Broich, K., Belleville, S., Brodaty, H., Bennett, D. A., Chertkow, H. M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 4,094
Self-citationAlzheimer's Disease Neuroimaging Initiative (ADNI)
Petersen, R. C., Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181cb3e25 · Cited by 2,572
Self-citationCerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065
Self-citation
Research works printed but not linked: 2
- [4]Petersen RC Petersen RC Conceptual Overview Mild Cognitive Impairment: Aging to Alzheimer’s Disease New York Oxford University Press, Inc 2003 1 14
- [27]Roberts R Geda Y Knopman D Men are More Likely to Have Mild Cognitive Impairment Than Women: The Mayo Clinic Study of Aging Neurology 2008 abstract (In press)
Cited by
Sorted by citations
Items 301–400 of 1,000
Tierney, M. C., & Lermer, M. A. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091672 · Cited by 64
Garand, L., Rinaldo, D. E., Alberth, M. M., Delany, J., Beasock, S. L., López, O. L., Reynolds, C. F., & Dew, M. A. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.07.007 · Cited by 58
Spatial navigation and risk of cognitive impairment: A prospective cohort study
Verghese, J., Lipton, R. B., & Ayers, E. I. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.01.023 · Cited by 67
Different Patterns of Theory of Mind Impairment in Mild Cognitive Impairment
Moreau, N., Rauzy, S., Bonnefoi, B., Renié, L., Martinez-Almoyna, L., Viallet, F., & Champagne‐Lavau, M. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143021 · Cited by 62
Serum Thyroid-Stimulating Hormone as a Predictor of Cognitive Impairment in an Elderly Cohort
Forti, P., Olivelli, V., Rietti, E., Maltoni, B., Pirazzoli, G. L., Gatti, R., Gioia, M. G., & Ravaglia, G. (2011) · Gerontology · doi:10.1159/000324522 · Cited by 57
Demyelination in Mild Cognitive Impairment Suggests Progression Path to Alzheimer’s Disease
Carmeli, C., Donati, A., Antille, V., Viceic, D., Ghika, J. A., von Gunten, A., Clarke, S., Meuli, R. A., Frackowiak, R. S. J., & Knyazeva, M. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072759 · Cited by 57
Barnes, D. E., Cenzer, I. S., Yaffe, K. S., Ritchie, C. S., Lee, S. J., & Initiative, A. D. N. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.12.014 · Cited by 57
Zheng, T., Qin, L., Chen, B., Hu, X., Zhang, X., Liu, Y., Liu, H., Qin, S., Li, G., & Li, Q. (2016) · Diabetes Care · doi:10.2337/dc16-0316 · Cited by 57
Ma, H. R., Sheng, L. Q., Pan, P. L., Wang, G. D., Luo, R., Shi, H. C., Dai, Z. Y., & Zhong, J. G. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0114-z · Cited by 57
Mansbach, W. E., & Mace, R. A. (2018) · The Gerontologist · doi:10.1093/geront/gny097 · Cited by 58
Atrial fibrillation in the elderly: a risk factor beyond stroke
Bencivenga, L., Komici, K., Nocella, P., Grieco, F. V., Spezzano, A., Puzone, B., Cannavò, A., Cittadini, A., Corbi, G., Ferrara, N., et al. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101092 · Cited by 58
Chuang, Y., Liu, Y., Tseng, H.-Y., Lin, P.-X., Li, C.-Y., Shih, M., Lin, K., Yang, T. O., Yan, S., & Chiu, Y. (2021) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2021.03.005 · Cited by 57
Sun, R., Ge, B., Wu, S., Li, H., & Lin, L. (2023) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2023.103691 · Cited by 56
Dewar, M., Pesallaccia, M., Cowan, N., Provinciali, L., & Sala, S. D. (2012) · Brain and Cognition · doi:10.1016/j.bandc.2011.12.005 · Cited by 59
Adiponectin, leptin and IL-1 β in elderly diabetic patients with mild cognitive impairment
Górska-Ciebiada, M., Saryusz‐Wolska, M., Borkowska, A., Ciebiada, M., & Loba, J. M. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9739-0 · Cited by 56
Neurobiology of cognitive impairment in Parkinson’s disease
Jellinger, K. A. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.131 · Cited by 59
Klados, M. A., Styliadis, C., Frantzidιs, C. A., Paraskevopoulos, E., & Bamidis, P. D. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00055 · Cited by 64
Scarabino, D., Peconi, M., Broggio, E., Gambina, G., Maggi, E., Armeli, F., Mantuano, E., Morello, M., Corbo, R. M., & Businaro, R. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110945 · Cited by 59
Effects of Amnestic Mild Cognitive Impairment on N2 and P3 Go/NoGo ERP Components
Cid‐Fernández, S., Lindı́n, M., & Dı́az, F. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130677 · Cited by 59
Ida, S., Nakai, M., Ito, S., Ishihara, Y., Imataka, K., Uchida, A., Monguchi, K., Kaneko, R., Fujiwara, R., Takahashi, H., et al. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.06.012 · Cited by 55
Orr, M. E., Kotkowski, E., Ramirez, P., Bair‐Kelps, D., Liu, Q., Brenner, C., Schmidt, M. S., Fox, P. T., Larbi, A., Tan, C. T. Y., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00999-9 · Cited by 61
Apóstolo, J., Holland, C., O’Connell, M. D. L., Feeney, J. C., Tabarés‐Seisdedos, R., Tadros, G., Campos, E. B., Santos, N. C., Robertson, D. A., Marcucci, M., et al. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.10.008 · Cited by 58
Lazarczyk, M. J., Hof, P. R., Bouras, C., & Giannakopoulos, P. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-127 · Cited by 55
Martínez, G., Vernooij, R. W. M., Padilla, P. F., Zamora, J., Flicker, L. A., & Bonfill, X. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012884 · Cited by 56
Recommendations for the Design of Serious Games in Neurodegenerative Diseases
Ben-Sadoun, G., Manera, V., Álvarez, J., Sacco, G., & Robert, P. H. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00013 · Cited by 55
Mitolo, M., Maserati, M. S., Capellari, S., Testa, C. M., Rucci, P., Poda, R., Oppi, F., Gallassi, R., Sambati, L., Rizzo, G., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101843 · Cited by 55
Weiner, M. W., Harvey, D. J., Landau, S. M., Veitch, D. P., Neylan, T. C., Grafman, J. H., Aisen, P. S. S., Petersen, R. C., Jack, C. R., Tosun, D., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12712 · Cited by 54
Self-citationDemirayak, P., Kıyı, İ., Özbek, Y., & Yener, G. (2023) · Scientific Reports · doi:10.1038/s41598-023-43132-8 · Cited by 54
A hybrid feature selection approach for the early diagnosis of Alzheimer’s disease
Gallego-Jutglà, E., Solé‐Casals, J., Vialatte, F., Elgendi, M., Cichocki, A. S., & Dauwels, J. (2015) · Journal of Neural Engineering · doi:10.1088/1741-2560/12/1/016018 · Cited by 54
Haller, S., Missonnier, P., Herrmann, F. R., Rodriguez, C. K., Deiber, M., Nguyen, D. D., Gold, G., Lövblad, K., & Giannakopoulos, P. (2012) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3223 · Cited by 56
Swaminathan, S., Shen, L., Risacher, S. L., Yoder, K. K., West, J. D., Kim, S., Nho, K. T., Foroud, T., Inlow, M. H., Potkin, S. G., et al. (2011) · Brain Imaging and Behavior · doi:10.1007/s11682-011-9136-1 · Cited by 54
Self-citationPrevalence and conversion to dementia of Mild Cognitive Impairment in an elderly Italian population
for the Dementia Registry Study Group, Limongi, F., Siviero, P., Noale, M., Gesmundo, A., Crepaldi, G., & Maggi, S. (2017) · Aging Clinical and Experimental Research · doi:10.1007/s40520-017-0748-1 · Cited by 54
Gomersall, T., Smith, S. K., Blewett, C., & Astell, A. J. (2017) · British Journal of Health Psychology · doi:10.1111/bjhp.12255 · Cited by 54
Freedman, M., Leach, L. R., Tartaglia, M. C., Stokes, K. A., Goldberg, Y., Spring, R., Nourhaghighi, N., Gee, T., Strother, S. C., Alhaj, M. O., et al. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0382-y · Cited by 54
Damian, M., Hausner, L., Jekel, K., Richter, M., Froelich, L., Almkvist, O., Boada, M., Bullock, R., De Deyn, P. P., Frisoni, G. B., et al. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000348354 · Cited by 53
Liang, X., Guo, Q., Luo, J., Li, F., Ding, D., Zhao, Q., & Hong, Z. (2016) · BMC Neurology · doi:10.1186/s12883-016-0712-2 · Cited by 53
Karimi, L., Ahari, A. M., Jahangiry, L., Sadeghi‐Bazargani, H., & Farahbakhsh, M. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-03730-8 · Cited by 56
Anstey, K. J., Cherbuin, N., Eramudugolla, R., Sargent‐Cox, K. A., Easteal, S., Kumar, R., & Sachdev, P. S. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.11.013 · Cited by 53
Biomarkers of Renal Function and Cognitive Impairment in Patients With Diabetes
Murray, A. M., Barzilay, J. I., Lovato, J. F., Williamson, J. D., Miller, M. E., Marcovina, S. M., Launer, L. J., & for the Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes (ACCORD-MIND) Substudy Investigators (2011) · Diabetes Care · doi:10.2337/dc11-0186 · Cited by 54
Hwang, J., Estick, C., Ikonne, U. S., Butler, D., Pait, M. C., Elliott, L. H., Ruiz, S., Smith, K., Rentschler, K. M., Mundell, C. T., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184432 · Cited by 55
Decreased retinal thickness in patients with Alzheimer’s disease is correlated with disease severity
Kim, J., & Kang, B.-H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224180 · Cited by 53
Kubota, A., Peterson, E. I. C., Rajendren, V., Kress‐Gazit, H., & Riek, L. D. (2020) · ACM/IEEE International Conference on Human-Robot Interaction (HRI) · doi:10.1145/3319502.3374836 · Cited by 56
Barber, S. E., Clegg, A. P., & Young, J. B. (2012) · Age and Ageing · doi:10.1093/ageing/afr138 · Cited by 52
Prospective biomarkers of Alzheimer’s disease: A systematic review and meta-analysis
Li, R., Ma, Y., Tan, L., & Yu, J. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101699 · Cited by 54
Samtani, M. N., Raghavan, N., Shi, Y., Novak, G., Farnum, M. A., Lobanov, V. S., Schultz, T., Yang, E., DiBernardo, A., Narayan, V. A., et al. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04308.x · Cited by 52
Trittschuh, E. H., Crane, P. K., Larson, E. B., Cholerton, B., McCormick, W. C., McCurry, S. M., Bowen, J. D., Baker, L. D., & Craft, S. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101821 · Cited by 52
Lister, J. J., Bush, A. L. H., Andel, R., Matthews, C., Morgan, D., & Edwards, J. D. (2015) · Clinical Neurophysiology · doi:10.1016/j.clinph.2015.11.007 · Cited by 52
Blumen, H. M., Brown, L. L., Habeck, C. G., Allali, G., Ayers, E. I., Beauchet, O., Callisaya, M. L., Lipton, R. B., Mathuranath, P. S., Phan, T. G., et al. (2018) · Brain Imaging and Behavior · doi:10.1007/s11682-018-9871-7 · Cited by 52
Forouzannezhad, P., Abbaspour, A., Li, C., Fang, C., Williams, U., Cabrerizo, M., Barreto, A. B., Andrian, J. H., Rishe, N. D., Curiel, R. E., et al. (2019) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2019.108544 · Cited by 52
Prediction of conversion to Alzheimer’s disease using deep survival analysis of MRI images
Nakagawa, T., Ishida, M., Naito, J., Nagai, A., Yamaguchi, S., Onoda, K., & Initiative, O. B. O. T. A. D. N. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa057 · Cited by 53
Son, C., & Park, J.-H. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192315875 · Cited by 51
Exploring the dual character of metformin in Alzheimer's disease
Ning, P., Luo, A., Mu, X. L., Xu, Y., & Li, T. X. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.108966 · Cited by 51
Mancuso, R., Baglio, F., Agostini, S., Cabinio, M., Laganà, M. M., Hernis, A., Margaritella, N., Guerini, F. R., Zanzottera, M., Nemni, R., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00285 · Cited by 51
Macera, C. A., Cavanaugh, A. M., & Bellettiere, J. (2015) · American Journal of Lifestyle Medicine · doi:10.1177/1559827615571897 · Cited by 58
Xie, B., Liu, Z., Jiang, L., Liu, W., Song, M. L., Zhang, Q., Zhang, R., Cui, D., Wang, X., & Xu, S. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160468 · Cited by 52
Xie, B., Xu, Y., Liu, Z., Liu, W., Jiang, L., Zhang, R., Cui, D., Zhang, Q., & Xu, S. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160954 · Cited by 51
Educational level and its Association with the domains of the Montreal Cognitive Assessment Test
Borda, M. G., Ortiz, C. A. R., Pérez‐Zepeda, M. U., Patiño-Hernández, D., Arteaga, R. C. G., & Cano, C. A. (2018) · Aging & Mental Health · doi:10.1080/13607863.2018.1488940 · Cited by 56
Julayanont, P., McFarland, N. R., & Heilman, K. M. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.116523 · Cited by 51
Memory Performance Correlates of Hippocampal Subfield Volume in Mild Cognitive Impairment Subtype
Broadhouse, K. M., Mowszowski, L., Duffy, S. L., Leung, I. H. K., Cross, N. E., Valenzuela, M., & Naismith, S. L. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00259 · Cited by 53
Granger, K. T., & Barnett, J. H. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.01.019 · Cited by 52
Mowszowski, L., Hermens, D. F., Diamond, K., Norrie, L. M., Hickie, I. B., Lewis, S. J. G., & Naismith, S. L. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111868 · Cited by 51
Chen, G., Cai, L., Chen, B., Liang, J., Lin, F., Li, L., Lin, L., Yao, J., Wen, J., & Huang, H. (2011) · Diabetes Care · doi:10.2337/dc11-0958 · Cited by 51
Jiang, L., Cui, H., Zhang, C., Cao, X., Gu, N., Zhu, Y., Wang, J., Yang, Z., & Li, C. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.593000 · Cited by 50
Fang, R., Wang, G., Huang, Y. M., Zhuang, J.-P., Tang, H., Wang, Y., Deng, Y., Xu, W. L., Chen, S., & Ren, R. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000353541 · Cited by 51
Assessment of Cognitive Decline Through Quantitative Analysis of the Timed Up and Go Test
Greene, B. R., & Kenny, R. A. (2011) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2011.2181844 · Cited by 50
Pußwald, G., Moser, D., Gleiß, A., Janzek‐Hawlat, S., Auff, E., Dal‐Bianco, P., & Lehrner, J. P. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.12.009 · Cited by 56
The transitional association between β‐amyloid pathology and regional brain atrophy
Insel, P. S., Mattsson, N., Donohue, M., Mackin, R. S., Aisen, P. S. S., Jack, C. R., Shaw, L. M. J., Trojanowski, J. Q., Weiner, M. W., & Initiative, A. D. N. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.11.002 · Cited by 51
Self-citationTimothy, L. T., Krishna, B. M., & Nair, U. (2017) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2017.07.006 · Cited by 50
Novel Technological Solutions for Assessment, Treatment, and Assistance in Mild Cognitive Impairment
Mancioppi, G., Fiorini, L., Sportiello, M. T., & Cavallo, F. (2019) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2019.00058 · Cited by 54
Bright Light Therapy and Circadian Cycles in Institutionalized Elders
Díaz, J. Á. R., Gamundı́, A., Akaârir, M., Cañellas, F., Rial, R. V., & Nicolau, M. C. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00359 · Cited by 52
Revision of the criteria for Alzheimer's disease: A symposium
DeKosky, S. T., Carrillo, M. C., Phelps, C. H., Knopman, D. S., Petersen, R. C., Frank, R., Schenk, D., Masterman, D. M., Siemers, E., Cedarbaum, J. M., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.12.007 · Cited by 52
Self-citationSavica, R., & Petersen, R. C. (2011) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.11.006 · Cited by 51
Self-citationLee, S. J., Ritchie, C. S., Yaffe, K. S., Cenzer, I. S., & Barnes, D. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113535 · Cited by 49
Copy Number Variants in Alzheimer’s Disease
Cuccaro, D., Marco, E. V. D., Cittadella, R., & Cavallaro, S. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160469 · Cited by 51
Carrasco, P. M., Montenegro-Peña, M., López-Higes, R., Estrada, E., Crespo, D. P., Rubio, C., & García‐Azorín, D. (2016) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2016.12.007 · Cited by 54
Panikker, P., Xu, S., Zhang, H., Sarthi, J. B., Beaver, M., Sheth, A., Akhter, S., & Elefant, F. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2840-17.2018 · Cited by 51
Iiboshi, K., Yoshida, K., Yamaoka, Y., Eguchi, Y., Sato, D., Kishimoto, M., Funaki, K., Mimura, M., & Kishimoto, T. (2019) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2019.0134 · Cited by 49
de Paula, J. J., de Paiva, R. E. R. P., Silva, N. G. S. E., Rosa, D. V., Duran, F., Coimbra, R. S., Costa, D. D. S., Dutenhefner, P. R., Oliveira, H. S. D., Camargos, S., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01632-5 · Cited by 51
The NINDS-Canadian stroke network vascular cognitive impairment neuropsychology protocols in Chinese
Wong, A., Xiong, Y., Wang, D., Lin, S., Chu, C. W., Kwan, P., Nyenhuis, D. L., Black, S. E., Wong, K. S., & Mok, V. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304041 · Cited by 49
Memory, executive, and multidomain subtle cognitive impairment
Toledo, J. B., Bjerke, M., Chen, K., Rozycki, M., Jack, C. R., Weiner, M. W., Arnold, S. E., Reiman, E. M., Davatzikos, C. A., Shaw, L. M. J., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001738 · Cited by 48
Self-citationKuiper, J. S., Smidt, N., Zuidema, S. U., Comijs, H. C., Voshaar, R. C. O., & Zuidersma, M. (2019) · Aging & Mental Health · doi:10.1080/13607863.2019.1571012 · Cited by 51
Dementia spectrum disorders: lessons learnt from decades with PET research
Wilson, H., Pagano, G., & Politis, M. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-01975-4 · Cited by 50
Boz, H. E., Limoncu, H., Zygouris, S., Tsolaki, M., Giakoumis, D., Votis, K., Tzovaras, D. K., Öztürk, V., & Yener, G. (2019) · Aging Neuropsychology and Cognition · doi:10.1080/13825585.2019.1663146 · Cited by 48
Sung, J. E., Choi, S., Eom, B., Yoo, J. K., & Jeong, J. H. (2020) · Journal of Speech Language and Hearing Research · doi:10.1044/2020_jslhr-19-00335 · Cited by 48
Morphological basis of Parkinson disease-associated cognitive impairment: an update
Jellinger, K. A. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02522-4 · Cited by 48
Subtyping of mild cognitive impairment using a deep learning model based on brain atrophy patterns
Kwak, K., Giovanello, K. S., Bozoki, A., Styner, M., & Dayan, E. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100467 · Cited by 47
Wood, J. L., Weıntraub, S., Coventry, C., Xu, J., Zhang, H., Rogalski, E. J., Mesulam, M. M., & Gefen, T. D. (2020) · Journal of the International Neuropsychological Society · doi:10.1017/s135561772000048x · Cited by 47
Xu, S., Xie, B., Song, M., Yu, L., Wang, L., An, C., Zhu, Q., Han, K., Zhao, X., Zhang, R., et al. (2014) · Neuroepidemiology · doi:10.1159/000357374 · Cited by 47
Neuropathology of Nonmotor Symptoms of Parkinson's Disease
Jellinger, K. A. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.005 · Cited by 50
Sun, C., Xiao, Y., Li, J., Ge, B., Chen, X., Liu, H., & Zheng, T. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12437 · Cited by 47
Peltz, C. B., Corrada, M. M., Berlau, D. J., & Kawas, C. H. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.02.008 · Cited by 47
Multi-Omics, an Integrated Approach to Identify Novel Blood Biomarkers of Alzheimer’s Disease
François, M., Karpe, A. V., Liu, J., Beale, D. J., Hor, M., Hecker, J. R., Faunt, J., Maddison, J., Johns, S., Doecke, J. D., et al. (2022) · Metabolites · doi:10.3390/metabo12100949 · Cited by 47
Serious games for screening pre-dementia conditions: from virtuality to reality? A pilot project.
Zucchella, C., Sinforiani, E., Tassorelli, C., Cavallini, E., Tost, D., Grau, S., Pazzi, S., Puricelli, S., Bernini, S., Bottiroli, S., et al. (2014) · Europe PMC (PubMed Central) · Cited by 46
Neuroanatomic basis of amnestic MCI differs in patients with and without Parkinson disease
Lee, J. E., Park, H., Song, S. K., Sohn, Y. H., Lee, J. D., & Lee, P. H. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ff96bf · Cited by 46
Mudar, R. A., Chiang, H., Eroh, J., Nguyen, L. T., Maguire, M. J., Spence, J. S., Kung, F., Kraut, M. A., & Hart, J. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150586 · Cited by 46
Cognitive status among patients with chronic obstructive pulmonary disease
Roncero, C., Campuzano, A., Quintano, J. A., Molina, J., Pérez, J., & Miravitlles, M. (2016) · International Journal of COPD · doi:10.2147/copd.s100850 · Cited by 46
Xie, L., Pluta, J. B., Das, S. R., Wisse, L. E. M., Wang, H., Mancuso, L., Kliot, D., Avants, B., Ding, S., Manjón, J. V., et al. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.09.070 · Cited by 47
Wang, D., Belden, A. G., Hanser, S. B., Geddes, M. R., & Loui, P. (2020) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2020.00280 · Cited by 46
Jiang, J., Wang, M., Alberts, I., Sun, X., Li, T., Rominger, A., Zuo, C., Han, Y., Shi, K., & Initiative, A. D. N. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05687-y · Cited by 46
Palesi, F., Castellazzi, G., Casiraghi, L., Sinforiani, E., Vitali, P., Wheeler‐Kingshott, C. A. M. G., & D'Angelo, E. U. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00380 · Cited by 48
Metadata
- Authors
- Petersen, R. C., Roberts, R. O., Knopman, D. S., Boeve, B. F., Geda, Y. E., Ivnik, R. J., Smith, G. E., & Jack, C. R.
- Affiliations
- Mayo Clinic (US)
- ORCID
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2009-12-01
- Volume
- 66
- Issue
- 12
- Pages
- 1447-55
- ISSN
- 0003-9942 (ISSN-L)
- PMC
- PMC3081688
- OpenAlex
- W1972982304
- Cited by
- 1,447
- References
- 59
- Citations by year
- 2026: 54 · 2025: 74 · 2024: 71 · 2023: 72 · 2022: 93 · 2021: 116 · 2020: 85 · 2019: 89 · 2018: 96 · 2017: 72 · 2016: 98 · 2015: 104 · 2014: 89 · 2013: 102 · 2012: 97
- FWCI
- 46.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Archives of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5u01ag024904-10)
- National Institute on Aging (U01-AG-024904, R01AG11378, P50‐AG16574, U01AG06786, U01AG006786, R01AG011378, U19AG010483, P50AG016574)
- National Institute of Mental Health (K01-MH68351, K01MH068351)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- mild cognitive impairment, Alzheimer's disease, dementia, biomarkers, neuroimaging, neuropathology, disease mechanisms, clinical trials
- MeSH terms
- Alzheimer Disease, Clinical Trials as Topic, Cognition Disorders, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
